Zimmer Biomet Holdings (ZBH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Zimmer Biomet Holdings (ZBH)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Key Insights
Critical company metrics and information
Share Price
$108.03Market Cap
$21.51 BillionTotal Outstanding Shares
199.07 Million SharesTotal Employees
18,000Dividend
$0.24 Per Share QuarterlyIPO Date
August 7, 2001SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesHomepage
https://www.zimmerbiomet.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $268.50 Million |
Net Cash Flow | $268.50 Million |
Net Cash Flow From Investing Activities | $-817.70 Million |
Net Cash Flow From Financing Activities, Continuing | $-495.30 Million |
Net Cash Flow From Investing Activities, Continuing | $-817.70 Million |
Net Cash Flow From Operating Activities | $1.58 Billion |
Net Cash Flow From Operating Activities, Continuing | $1.58 Billion |
Net Cash Flow From Financing Activities | $-495.30 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Operating Expenses | $4.20 Billion |
Net Income/Loss | $1.08 Billion |
Interest Income/Expense Operating, Net | $-206.40 Million |
Gross Profit | $5.45 Billion |
Income Tax Expense/Benefit | $-52.70 Million |
Costs And Expenses | $6.34 Billion |
Benefits Costs and Expenses | $6.56 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $1.08 Billion |
Diluted Average Shares | $204.80 Million |
Operating Income/Loss | $1.25 Billion |
Income/Loss From Continuing Operations After Tax | $1.08 Billion |
Net Income/Loss Attributable To Parent | $1.08 Billion |
Cost Of Revenue | $2.14 Billion |
Interest Income/Expense After Provision For Losses | $-206.40 Million |
Income/Loss From Continuing Operations Before Tax | $1.03 Billion |
Provision For Loan, Lease, And Other Losses | $0.00 |
Basic Average Shares | $204.10 Million |
Revenues | $7.60 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Other Operating Expenses | $344.40 Million |
Basic Earnings Per Share | $5.27 |
Diluted Earnings Per Share | $5.24 |
Selling, General, and Administrative Expenses | $2.91 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Net Income/Loss Attributable To Noncontrolling Interest | $1.30 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Assets | $21.72 Billion |
Other Current Assets | $2.50 Billion |
Other Current Liabilities | $3.25 Billion |
Noncurrent Liabilities | $5.77 Billion |
Noncurrent Assets | $16.86 Billion |
Intangible Assets | $4.67 Billion |
Equity Attributable To Parent | $12.37 Billion |
Equity | $12.38 Billion |
Current Liabilities | $3.57 Billion |
Liabilities And Equity | $21.72 Billion |
Fixed Assets | $2.11 Billion |
Equity Attributable To Noncontrolling Interest | $8.50 Million |
Inventory | $2.37 Billion |
Other Non-current Assets | $10.08 Billion |
Current Assets | $4.86 Billion |
Liabilities | $9.34 Billion |
Accounts Payable | $322.40 Million |
Historical Dividends
Current dividend: $0.24 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Aug 29, 2024 | Oct 31, 2024 | Sep 30, 2024 | $0.24 | Quarterly |
May 13, 2024 | Jul 31, 2024 | Jun 26, 2024 | $0.24 | Quarterly |
Feb 21, 2024 | Apr 30, 2024 | Mar 29, 2024 | $0.24 | Quarterly |
Dec 14, 2023 | Jan 31, 2024 | Dec 27, 2023 | $0.24 | Quarterly |
Aug 25, 2023 | Oct 31, 2023 | Sep 29, 2023 | $0.24 | Quarterly |
May 15, 2023 | Jul 31, 2023 | Jun 26, 2023 | $0.24 | Quarterly |
Mar 8, 2023 | Apr 28, 2023 | Mar 29, 2023 | $0.24 | Quarterly |
Dec 15, 2022 | Jan 31, 2023 | Dec 27, 2022 | $0.24 | Quarterly |
Aug 26, 2022 | Oct 31, 2022 | Sep 30, 2022 | $0.24 | Quarterly |
May 17, 2022 | Jul 29, 2022 | Jun 27, 2022 | $0.24 | Quarterly |
Feb 22, 2022 | Apr 29, 2022 | Mar 29, 2022 | $0.24 | Quarterly |
Nov 16, 2021 | Jan 31, 2022 | Dec 28, 2021 | $0.24 | Quarterly |
Sep 3, 2021 | Oct 29, 2021 | Sep 30, 2021 | $0.24 | Quarterly |
Jun 10, 2021 | Jul 30, 2021 | Jun 28, 2021 | $0.24 | Quarterly |
Mar 11, 2021 | Apr 30, 2021 | Mar 29, 2021 | $0.24 | Quarterly |
Dec 16, 2020 | Jan 29, 2021 | Dec 28, 2020 | $0.24 | Quarterly |
Sep 10, 2020 | Oct 30, 2020 | Sep 30, 2020 | $0.24 | Quarterly |
Jun 11, 2020 | Jul 31, 2020 | Jun 29, 2020 | $0.24 | Quarterly |
Mar 10, 2020 | Apr 30, 2020 | Mar 27, 2020 | $0.24 | Quarterly |
Dec 16, 2019 | Jan 31, 2020 | Dec 27, 2019 | $0.24 | Quarterly |
Sep 3, 2019 | Oct 31, 2019 | Sep 30, 2019 | $0.24 | Quarterly |
Jun 11, 2019 | Jul 31, 2019 | Jun 28, 2019 | $0.24 | Quarterly |
Mar 7, 2019 | Apr 30, 2019 | Mar 29, 2019 | $0.24 | Quarterly |
Dec 12, 2018 | Jan 31, 2019 | Dec 28, 2018 | $0.24 | Quarterly |
Sep 13, 2018 | Oct 31, 2018 | Sep 28, 2018 | $0.24 | Quarterly |
Jun 14, 2018 | Jul 31, 2018 | Jun 29, 2018 | $0.24 | Quarterly |
Mar 12, 2018 | Apr 30, 2018 | Mar 29, 2018 | $0.24 | Quarterly |
Dec 18, 2017 | Jan 29, 2018 | Dec 29, 2017 | $0.24 | Quarterly |
Aug 7, 2017 | Oct 27, 2017 | Sep 22, 2017 | $0.24 | Quarterly |
May 30, 2017 | Jul 28, 2017 | Jun 23, 2017 | $0.24 | Quarterly |
Mar 1, 2017 | Apr 28, 2017 | Mar 31, 2017 | $0.24 | Quarterly |
Dec 19, 2016 | Jan 27, 2017 | Dec 30, 2016 | $0.24 | Quarterly |
Aug 23, 2016 | Oct 28, 2016 | Sep 23, 2016 | $0.24 | Quarterly |
Feb 24, 2016 | Apr 29, 2016 | Mar 31, 2016 | $0.24 | Quarterly |
Dec 14, 2015 | Jan 29, 2016 | Dec 31, 2015 | $0.22 | Quarterly |
Aug 24, 2015 | Oct 30, 2015 | Sep 30, 2015 | $0.22 | Quarterly |
May 5, 2015 | Jul 14, 2015 | May 15, 2015 | $0.22 | Quarterly |
Feb 20, 2015 | Apr 24, 2015 | Mar 6, 2015 | $0.22 | Quarterly |
Dec 12, 2014 | Jan 30, 2015 | Dec 29, 2014 | $0.22 | Quarterly |
Aug 26, 2014 | Oct 31, 2014 | Sep 26, 2014 | $0.22 | Quarterly |
May 6, 2014 | Jul 25, 2014 | Jun 27, 2014 | $0.22 | Quarterly |
Feb 28, 2014 | Apr 25, 2014 | Mar 28, 2014 | $0.22 | Quarterly |
Dec 13, 2013 | Jan 31, 2014 | Dec 27, 2013 | $0.2 | Quarterly |
Jul 15, 2013 | Oct 25, 2013 | Sep 27, 2013 | $0.2 | Quarterly |
May 7, 2013 | Jul 26, 2013 | Jun 28, 2013 | $0.2 | Quarterly |
Feb 22, 2013 | Apr 26, 2013 | Mar 28, 2013 | $0.2 | Quarterly |
Dec 11, 2012 | Jan 25, 2013 | Dec 27, 2012 | $0.18 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Zimmer Biomet Holdings (ZBH)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.